Impact of beta1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockers
- 15 May 1987
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (13) , F44-F47
- https://doi.org/10.1016/0002-9149(87)90041-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- AcebutololDrugs, 1985
- Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactionsPharmacology & Therapeutics, 1983
- Can the biochemical responses to a beta 2‐adrenoceptor stimulant be used to assess the selectivity of beta‐adrenoceptor blockers?British Journal of Clinical Pharmacology, 1983
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction:the continuing controversyAmerican Heart Journal, 1980
- Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.Published by Wiley ,1978
- Beta-blockers and asthma.Heart, 1978
- Controlled study of the bronchoconstriction effect of pindolol administered intravenously or orally to patients with unstable asthmaEuropean Journal of Clinical Pharmacology, 1978
- Interaction of orally administered metoprolol, practolol and propranolol with isoprenaline in asthmaticsEuropean Journal of Clinical Pharmacology, 1976
- Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.BMJ, 1975
- Effect of propranolol on ventilatory functionThe American Journal of Cardiology, 1966